HuidaGene Therapeutics Co., Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by HuidaGene Therapeutics Co., Ltd.
RECRUITINGEarly Phase 1NCT07063251
An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease
Stargardt disease type 1 (STGD1) is a rare genetic eye condition that causes progressive vision loss, often beginning in childhood or adolescence. It is the most common form of...
Sponsor: HuidaGene Therapeutics Co., Ltd.Enrolling: 61 location
Stargardt Disease Type 1 (STGD1)
RECRUITINGEarly Phase 1NCT06031727
CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration...
Age-related macular degeneration (AMD) is a progressive disease leading to severe and irreversible vision loss of which the neovascular AMD (nAMD) accounted for 90% blindness in...
Sponsor: HuidaGene Therapeutics Co., Ltd.Enrolling: 122 locations
Neovascular Age-related Macular Degeneration(nAMD)